$1.36
+0.09 (+7.09%)
Open$1.30
Previous Close$1.27
Day High$1.44
Day Low$1.30
52W High$39.83
52W Low$19.87
Volume—
Avg Volume234.5K
Market Cap47.89M
P/E Ratio44.95
EPS$0.66
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+2,294.9% upside
Current
$1.36
$1.36
Target
$32.57
$32.57
$26.16
$32.57 avg
$50.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 10.28M | 9.86M | 9.80M |
| Net Income | -1,154,434 | -865,846 | -1,110,362 |
| Profit Margin | -11.2% | -8.8% | -11.3% |
| EBITDA | -1,433,621 | -1,413,990 | -1,277,421 |
| Free Cash Flow | -904,387 | -870,700 | -861,997 |
| Rev Growth | +11.1% | +6.2% | +2.7% |
| Debt/Equity | 0.32 | 0.28 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |